The therapeutic agents that target ATP-sensitive potassium channels
Acta Pharmaceutica · 01.03.2016 · 66 (1) · 23-34
DOI: 10.1515/acph-2016-0006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica, online erschienen am 07.03.2016. Verfasst von Hussein N Rubaiy. Beteiligte Einrichtung: School of Medicine, The Leeds Institute of Cardiovascular and Metabolic Medicine, Univiersity of Leeds, U.K. h.rubaiy@leeds.ac.uk. Die Arbeit wurde bisher 60-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
ATP-sensitive potassium (K ATP ) channels are a major drug target for the treatment of type-2 diabetes. K ATP channels are ubiquitously expressed and link the metabolic state to electrical excitability. In pancreatic β-cells, K ATP channels are crucial in the regulation of glucose-induced insulin secretion. Also, K ATP channels are involved in the protection against neuronal seizures and ischaemic stress in the heart, brain and in the regulation of vascular smooth muscle tone. Functional K ATP channels are hetero-octamers composed of two subunits, a pore forming Kir6, which is a member of the inwardly rectifying potassium channels family, and a regulatory sulphonylurea receptor (SUR). In response to nucleotides and pharmaceutical agonists and antagonists, SUR allosterically regulates channel gating. The allosteric communication pathways between these two heterologus proteins in K ATP channels are still poorly understood. This review will highlight the therapeutic agents that target K ATP channels and are used to treat diabetes and cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine, The Leeds Institute of Cardiovascular and Metabolic Medicine, Univiersity of Leeds, U.K. h.rubaiy@leeds.ac.uk
Zitieren
APA
Rubaiy, H. N. (2016). The therapeutic agents that target ATP-sensitive potassium channels. Acta Pharmaceutica, 66(1), 23-34. https://doi.org/10.1515/acph-2016-0006
Vancouver
Rubaiy HN. The therapeutic agents that target ATP-sensitive potassium channels. Acta Pharmaceutica. 2016;66(1):23-34. doi:10.1515/acph-2016-0006
BibTeX
@article{Rubaiy2016,
author = {Rubaiy, Hussein N},
title = {The therapeutic agents that target ATP-sensitive potassium channels},
journal = {Acta Pharmaceutica},
year = {2016},
volume = {66},
number = {1},
pages = {23--34},
doi = {10.1515/acph-2016-0006}
}
EUVIMED